Since the emergence of the COVID-19 pandemic, there has been increased interest in developing a universal antiviral that would stop a pandemic in its tracks.

U.S. drugmaker Eli Lilly said on March 15 the company would continue to supply drugs for urgent medical conditions such as cancer and diabetes to Russia, but will suspend all investments and no longer start new clinical studies in the country.

In response to the ongoing Russian invasion of Ukraine, Pfizer will cease operations within Russia and proceeds from the company’s subsidiary in that country will be donated to provide direct humanitarian support to the people of Ukraine. Regarding COVID-19, Pfizer Chief Executive Officer Albert Bourla noted in an interview with Face the Nation that it is likely that a fourth booster shot of the company’s vaccine will be needed to fend off another surge of infections.

Vanessa Brill, Vice President and Regional General Counsel for Dr. Reddy’s Laboratories operations in the Americas, discusses various topics including what she looks for in outside legal counsels and drug supply chain issues.

Republican and Democratic U.S. senators called for a government analysis of foreign influence in the U.S. pharmaceutical supply chain, saying the coronavirus pandemic has exposed an over-reliance on China and other countries for the production of essential drugs.